National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
NHI Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
National Health Investors, Inc.NYSE: NHI
Other Income / Expenses · Q3 FY2026 · quarter ended Sep 2026
Other income / expenses turns positive
Q3 FY2026 other income / expenses was $533.04M, compared with -$11.6M a year earlier. Trailing-twelve-month other income / expenses was $514.19M.
Context
- Other income / expenses amounted to 14.3% of revenue in FY2025, up 0.2 pp from a year earlier.
- Other income / expenses grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other income / expenses holds near $533.04M or moves back toward the trailing-twelve-month quarterly average of $128.55M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (54.04M) USD
- Year-over-year change
- -14.3%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (54.04M) | -14.3% |
| FY2024 | 2024-12-31 | (47.26M) | -6.4% |
| FY2023 | 2023-12-31 | (44.41M) | +34.1% |
| FY2022 | 2022-12-31 | (67.35M) | +8.0% |
| FY2021 | 2021-12-31 | (73.22M) | — |
Other Income / Expenses vs competitors
How NHI compares with its peers on the latest reported figures
- NHI's LTM Sep 2026 other income / expenses of $514.19M is the highest of the 9 companies compared; the peer median is -$93.88M.
- Its year-over-year change of +1460.2% is the highest of 9, against a peer median of +16.7%.
- Other income / expenses amounts to 112.5% of revenue for NHI, versus a peer median of 7.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $514.19M | +1460.2% | — | 112.5% | |
| LTM Sep 2026 | $80.59M | +112.9% | — | 1.6% | |
| LTM Jun 2026 | -$62.26M | +14.1% | — | 7.9% | |
| LTM Jun 2026 | -$66.12M | +24.6% | — | 7.7% | |
| LTM Jun 2026 | -$84.94M | +25.4% | — | 17.8% | |
| LTM Sep 2026 | -$102.83M | -115.3% | — | 5.6% | |
| LTM Jun 2026 | -$137.08M | +19.3% | — | 18.8% | |
| LTM Sep 2026 | -$360.4M | -88.7% | — | 3.3% | |
| LTM Mar 2026 | -$736.38M | -645.4% | — | 61.0% | |
| Peer median (excluding NHI) | -$93.88M | +16.7% | — | 7.8% | |
Competitors are the stored peer set for NHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 298.72M | 278.19M | 319.84M | 335.18M | 378.53M |
| Cost of Revenue | 11.64M | 9.79M | 11.51M | 11.17M | 239.6M |
| Gross Profit | 287.08M | 268.41M | 308.32M | 324.02M | 138.93M |
| Gross Margin | 96.1% | 96.5% | 96.4% | 96.7% | 36.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.34M | 25.32M | 19.82M | 21.79M | 0 |
| Operating Expenses | 101.83M | 135.64M | 129.53M | 140.16M | (55.9M) |
| Depreciation & Amortization | 80.8M | 70.88M | 69.97M | 71.44M | 83.85M |
| EBITDA | 240.94M | 178.73M | 259.87M | 264.16M | 282M |
| EBITDA Margin | 80.7% | 64.2% | 81.3% | 78.8% | 74.5% |
| Operating Income | 185.25M | 132.77M | 178.79M | 183.86M | 194.83M |
| Operating Margin | 62.0% | 47.7% | 55.9% | 54.9% | 51.5% |
| Interest Income | 0 | 0 | (2.65M) | 0 | 23.82M |
| Interest Expense | 48.11M | 42.44M | 55.51M | 56.12M | 57.37M |
| Other Income / Expenses | (73.22M) | (67.35M) | (44.41M) | (47.26M) | (54.04M) |
| Income Before Tax | 112.03M | 65.41M | 134.38M | 136.59M | 140.79M |
| Pre-Tax Margin | 37.5% | 23.5% | 42.0% | 40.8% | 37.2% |
| Income Tax Expense | 66K | (89K) | 0 | (45K) | 0 |
| Net Income | 111.8M | 66.4M | 135.65M | 137.99M | 142.18M |
| Net Margin | 37.4% | 23.9% | 42.4% | 41.2% | 37.6% |
| EPS (Basic) | 1.36 | 0.52 | 3.13 | 3.14 | 3.03 |
| EPS (Diluted) | 1.36 | 0.51 | 3.13 | 3.13 | 3.02 |
| Weighted Avg Shares | 45.71M | 44.77M | 43.39M | 43.85M | 46.88M |
| Weighted Avg Shares (Diluted) | 45.73M | 44.79M | 43.39M | 44.1M | 47.05M |
National Health Investors, Inc.
NYSE:NHI
Intrinsic Alpha fair value
Locked
Current Price
$62.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.